Anti-RhD Immunoglobulin for the Prevention of Haemolytic Disease

Marcela Contreras, Наталья Глебовна Оловникова(National Medical Research Center for Hematology), Belinda M. Kumpel(NHS Blood and Transplant)

The Global Library of Women s Medicine

January 1, 2023

10.3843/glowm.418843

Cited by 2

Related Papers

A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy

|Blood|2013|226

Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.

|PubMed|1994|107

Mechanism of anti-D-mediated immune suppression – a paradox awaiting resolution?

|Trends in Immunology|2001|103

Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti‐D immunoglobulin: more questions than answers

|Vox Sanguinis|2007|97

Human monoclonal anti‐D antibodies. I. THEIR PRODUCTION, SEROLOGY, QUANTITATION AND POTENTIAL USE AS BLOOD GROUPING REAGENTS

|British Journal of Haematology|1989|93